Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    4818200 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Study of Ezetimibe for Chronic Hepatitis C Virus (HCV) Infection in Liver Transplant Candidates (EZE-2)
Condition: Hepatitis C
Intervention: Drug: Ezetimibe
2 Completed Caloric Restriction and Insulin Secretion
Conditions: Morbid Obesity;   Type 2 Diabetes Mellitus
Intervention: Behavioral: Very Low Calorie Diet

Study has passed its completion date and status has not been verified in more than two years.